USE OF LOW-DOSE ERYTHROPOIETIN FOR THE TREATMENT OF ACUTE OR CHRONIC KIDNEY FAILURE AND FOR THE TREATMENT OF WOUNDS

摘要

The invention relates to the use of low-dose erythropoietin for stimulating physical mobilization, proliferation, and differentiation of endothelial precursor cells, stimulating vasculogenesis, treating diseases that are linked to a dysfunction of endothelial precursor cells, and producing pharmaceutical compositions used for the treatment of such diseases as well as pharmaceutical compositions containing erythropoietin and other appropriate agents for stimulating endothelial precursor cells.